D3566
Anti-DcR1 antibody produced in rabbit
~0.5 mg/mL, affinity isolated antibody, buffered aqueous solution
Synonym(s):
Anti-Decoy Receptor 1, Anti-LIT, Anti-TRAIL-R3, Anti-TRID
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
MDL number:
UNSPSC Code:
12352203
biological source
rabbit
conjugate
unconjugated
antibody form
affinity isolated antibody
antibody product type
primary antibodies
clone
polyclonal
form
buffered aqueous solution
mol wt
antigen ~65 kDa
species reactivity
mouse, rat, human
concentration
~0.5 mg/mL
technique(s)
microarray: suitable
western blot: 0.5-1 μg/mL
UniProt accession no.
shipped in
dry ice
storage temp.
−20°C
Gene Information
human ... TNFRSF10C(8794)
General description
DcR1 is found in most normal human tissue, but not in most cancer cell lines. It is a member of the TNF family of TRAIL (TNF-related apoptosis-induced ligand) receptors.
Immunogen
synthetic peptide corresponding to amino acids 111-123 at the extracellular domain of human DcR1 precursor.
Application
Anti-DcR1 antibody produced in rabbit is suitable for immunoblotting at a working concentration of 0.5-1μg/mL using human HeLa cells and mouse and rat liver tissue lysates.
Biochem/physiol Actions
DcR1 is a glycosylphosphatidylinositol-linked membrane protein that binds TRAIL (APO2 ligand). It acts as a decoy receptor and binds TRAIL to its extracellular TRAIL-binding domain, thus inhibiting TRAIL-mediated apoptosis. It does not have an intracellular death domain and, therefore, does not induce apoptosis.
Physical form
Solution in phosphate buffered saline containing 0.02% sodium azide.
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Not finding the right product?
Try our Product Selector Tool.
Storage Class
12 - Non Combustible Liquids
wgk_germany
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
T S Griffith et al.
Current opinion in immunology, 10(5), 559-563 (1998-10-31)
Apoptosis research is benefiting from bioinformatic approaches to identify new components of the cell death machinery and novel cell death inducers/receptors. Over the past year, knowledge of the system involving TNF-related apoptosis-inducing ligand (TRAIL) and its receptors has increased via
P Golstein
Current biology : CB, 7(12), R750-R753 (1998-02-21)
A cell-death signaling system has been described recently that involves the ligand TRAIL and corresponding TRAIL-specific cell-surface receptors. These include two receptors able to transduce a death signal and, as a previously unsuspected control mechanism, two other receptors able to
G Pan et al.
Science (New York, N.Y.), 277(5327), 815-818 (1997-08-08)
TRAIL, also called Apo2L, is a cytotoxic protein that induces apoptosis of many transformed cell lines but not of normal tissues, even though its death domain-containing receptor, DR4, is expressed on both cell types. An antagonist decoy receptor (designated as
J P Sheridan et al.
Science (New York, N.Y.), 277(5327), 818-821 (1997-08-08)
TRAIL (also called Apo2L) belongs to the tumor necrosis factor family, activates rapid apoptosis in tumor cells, and binds to the death-signaling receptor DR4. Two additional TRAIL receptors were identified. The receptor designated death receptor 5 (DR5) contained a cytoplasmic
Active Filters
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service
